Aprea Therapeutics CFO John Hamill's 2023 pay jumps 62% to $908K
Aprea Therapeutics reports 2023 executive compensation
By ExecPay News
Published: April 25, 2024
Aprea Therapeutics reported fiscal year 2023 executive compensation information on April 25, 2024.
In 2023, three executives at Aprea Therapeutics received on average a compensation package of $729K, a 20% decrease compared to previous year.
Average pay of disclosed executives at Aprea Therapeutics
John P. Hamill, Chief Financial Officer, received $908K in total. 43% of Hamill's compensation, or $388K, was in salary. Hamill also received $189K in non-equity incentive plan, $197K in option awards, as well as $134K in stock awards.
Oren Gilad, Chief Executive Officer, received a compensation package of $877K, which increased by 16% compared to previous year. 63% of the compensation package, or $550K, was in salary.
Scott M. Coiante, Chief Financial Officer, earned $400K in 2023, a 61% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 25, 2024.